INTRODUCTION
• A 62-year-old female with bipolar disorder presented to ED with lethargy, confusion and reduced mobility.
• Past medical history: bipolar disorder, hypothyroidism and recurrent UTIs.
• Medication history: lithium (>10 years duration), diazepam, olanzapine, sodium valproate and levothyroxine.
• She remained persistently hypernatraemic with Na >170mmol/L despite commencement of intravenous fluids.
• 10 days after admission, her blood glucose was noted to be 35mmol/L with serum osmolality of 398mOsm/kg
• She was deemed to be in HHS and treatment commenced with fixed rate insulin infusion and 0.9% saline.
• Over the next few days, the patient's clinical state deteriorated and she was transferred to ITU.
• Despite a fall in blood glucose, her plasma Na remained persistently elevated despite intravenous 0.45% saline.
• She remained polyuric with an increasing plasma osmolality and a low urine osmolality. This prompted the consideration of nephrogenic DI as a concomitant pathology.
• Overnight water deprivation test confirmed the diagnosis of DI
CASE HISTORY
• Amiloride with hydrochlorothiazide was started as treatment for nephrogenic DI.
• Subsequent improvement was observed with falling serum osmolalities and plasma sodium.
• Her plasma glucose remained stable on oral antihyperglycaemic agents.
MANAGEMENT INITIAL INVESTIGATIONS

Bloods:
Hb 109g/dL, WCC 12 x 10 9 /l , Neu 9.0 x 10 9 /l Na 143mmol/L, K 4.0mmol/L, Urea 7mmol/L, Cr 98mmol/L TFTs-normal Lithium levels 1mmol/L (0. Discussion & Learning Points
• Nephrotoxic renal effects of lithium may occur even within what is considered a therapeutic range.
• Lithium acts through entering the collecting ducts through epithelial sodium channels (ENaC) and inhibits signalling pathways (adenylate cyclase and glycogen synthase3-beta) causing disruption of the aquaporin-2 structure. These changes are initially reversible but thereafter can become permanent.
• Following recovery of hyperglycaemia, persistent polyuria and hyperosmolar state, should prompt consideration of differentials to include diabetes insipidus.
• Amiloride and hydrochlorthiazide are effective in the treatment of nephrogenic diabetes insipidus.
• It is important to recognise the two conditions may coexist in the same patient, so that appropriate therapies may be initiated. Diabetes and cardiovascular
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